nemo fish

Happy Thanksgiving Eve, everyone. While Thanksgiving is usually a happy holiday, it can also get a bit awkward at the dinner table, when politics are brought up. This year could be especially bad, considering we're just weeks removed from the results of the 2024 presidential election, when Donald Trump topped Kamala Harris, winning 312 Electoral College votes. One USA TODAY writer is even suggesting that President Biden "cancel" Thanksgiving this year, due to the heated political climate . "In the wake of the presidential election," Huppke writes . "The last thing any of us need to be doing is walking into potentially volatile mixed-ideology settings that often feature alcohol, long-standing feelings of familial resentment and easily thrown pies." While that's obviously an overreaction, it often does get political at the Thanksgiving dinner table. But everyone in the Manning family is probably on the same side, at least that we know of. Jeff Bottari/Getty Images Peyton and Eli Manning have made it pretty clear where they stand politically over the years. The two legendary NFL quarterbacks have reportedly shown support for the Republican Party. Peyton Manning has appeared at GOP events and donated to Republican Party candidates, while Eli Manning has admitted to being friendly with Donald Trump. Peyton Manning, a two-time Super Bowl champion and one of the best players of the 21st century, has reportedly been a "longstanding" donor to the party. The legendary NFL quarterback had reportedly been a "longstanding" supporter of the Republican Party. He had reportedly donated close to $20,000 to Republican candidates, according to USA TODAY. Manning reportedly donated to past presidential candidates like Mitt Romney and Jeb Bush. The latter of which joked about Manning's support following the Super Bowl. NFL fans, meanwhile, aren't too shocked by this. After all, the Manning family grew up in the South, attending SEC schools and has made a lot of money. It doesn't take a rocket scientist to guess that they are probably right-leaning. "Two rich guys who grew up in the south with a rich dad. Wow it’s a big surprise," one NFL fan wrote. "I care , I'm glad they are smart enough to support the Republican candidates...USA USA...," one fan added. Instagram. Thanksgiving Weekend will be a special one for the Manning family this year, too. Texas, where Arch Manning plays, is set to take on Texas A&M in a special rivalry game on Saturday. ESPN's College GameDay will be broadcasting live from the campus of Texas A&M on Saturday morning.Belarusian Opposition Figure Extradited Amid Intensified Crackdown

Middle East latest: Israel agrees to a ceasefire with Hezbollah in LebanonNone

Wunderdogs Unveils Report on the Next Generation of Climate Tech Startups, in Collaboration with True Ventures, Wireframe Ventures, Planeteer Capital, Activate and Prelude VenturesOldacre scores 21 points as No. 5 Texas routs Texas Rio Grande Valley 94-35Schwab Charles Corp executive sells $188k in stock

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here . 24/7 San Diego news stream: Watch NBC 7 free wherever you are Inflation in October ticked up The personal consumption expenditures price index for October ticked up 0.2% on the month and 2.3% on a 12-month basis, according to the U.S. Commerce Department on Wednesday. Core inflation rose 0.3% on the month and showed an annual reading of 2.8%, higher than September's 2.7%. All figures were in with Dow Jones consensus estimates. U.S. markets break rally U.S. stock markets fell on Wednesday , with the S&P 500 snapping its seven-day winning streak. Bond prices rose as Treasury yields slipped . Asia-Pacific stocks mostly rose on Thursday . Australia's S&P/ASX 200 climbed 0.45% to close at a new record. South Korea's blue-chip Kospi index was flat after the country's central bank lowered rates. South Korea unexpectedly cuts rates On Thursday, the Bank of Korea cut its benchmark interest rate by 25 basis points to 3%. A Reuters poll of economists had expected the BOK to keep rates unchanged. South Korea reported last month disappointing third-quarter economic growth of just 0.1% from a quarter earlier. The BOK on Thursday lowered its 2024 gross domestic product outlook to 2.2% from 2.4%. Offshore yuan might drop to lowest level China's offshore yuan is projected to fall to an average of 7.51 against the dollar by the end of 2025, according to CNBC's calculation of forecasts from 13 institutions. That would be the offshore yuan's lowest level on record , going by LSEG data dating back to 2004. Tariff threats and lower interest rates in China are putting pressure on the yuan. [PRO] Potential beneficiaries of tariffs U.S. President-elect Donald Trump's planned tariffs are worrying both investors and companies because higher import fees will raise costs. That said, those tariffs could benefit five technology companies that specialize in helping companies optimize supply chains. Money Report OPEC+ postpones meeting to decide oil production strategy to Dec. 5, delegates say From AI to young new artists, London wants to attract a new generation of art buyers In preparation for a heavy meal of turkey and stuffing and pumpkin pie, investors in the U.S. kept their trading appetite light. The SPDR S&P 500 , an exchange-traded fund that tracks the broad-based index, traded around 22.6% fewer shares than its 30-day average. So even though the S&P fell 0.38% to break its seven-day winning streak and the Dow Jones Industrial Average slid 0.31%, those moves don't seem to be a sell-off sparked by mass panic. Instead, traders appear to be giving thanks to the year's rally in Big Tech stocks by taking profit on them, which caused the Nasdaq Composite to drop a relatively steeper 0.6%. The fact that inflation in the U.S., on an annualized basis, ticked up by 0.1 percentage point from the previous month didn't seem to faze investors much either, probably because it wasn't an unexpected increase. In fact, traders boosted their bets that the U.S. Federal Reserve will lower rates by 25 basis points at its December meeting. The market is pricing in a 68.2% chance of that happening, higher than the 55.7% of a week ago, according to the CME FedWatch tool . "Today's data shouldn't change views of the likely path for disinflation, however bumpy," said David Alcaly, lead macroeconomic strategist at Lazard Asset Management. Echoing his views, Scott Helfstein, Global X's head of investment strategy, says he thinks the Fed "can eat turkey and watch football for a day knowing that they are close to full employment with price stability." Investors can also throw themselves into the festivities. More than three-quarters of stocks in the S&P are above their 200-day moving average, suggesting a steady upward trend and a market "still solid," according to Chris Verrone, head of the technical and macro research at Strategas. That's plenty of things to be grateful for this Thanksgiving. — CNBC's Jeff Cox, Scott Schnipper, Alex Harring and Sean Conlon contributed to this report. Also on CNBC U.S. inflation edged up but investors aren’t fazed The markets are living in Trump’s world for now A new day, a new Trump policy for markets to digestWhat's better than receiving passive income? Enjoying it for decades. Generating long-term passive income is easier than you might think. Here are three stocks to buy now and hold forever for a lifetime of dividends. 1. AbbVie Let's start with some bona fide dividend royalty. AbbVie ( ABBV -0.08% ) is a Dividend King , with 52 consecutive years of dividend increases. We're not talking about skimpy dividend hikes. Since its spinoff from Abbott Labs in 2013, AbbVie has increased its dividend payout by 310%. The big drugmaker's forward dividend yield currently stands at nearly 3.6%. That's on the low end of AbbVie's dividend yield range in recent years. But there's a good reason for this: AbbVie stock has performed well. I expect AbbVie to continue delivering share price appreciation and growing dividends over the next decade and beyond. Although sales are sliding for the company's top-selling drug, Humira, due to a loss of patent exclusivity, AbbVie has a strong product lineup and pipeline that's stepping up to the plate. In particular, autoimmune disease drugs Rinvoq and Skyrizi should drive AbbVie's revenue growth over the next few years. However, the company has plenty of other rising stars, including migraine therapies Ubrelvy and Qulipta, leukemia drug Venclexta, and antipsychotic drug Vraylar. AbbVie's pipeline also holds tremendous potential, with over 90 programs in clinical development -- more than 50 of which are in mid-to-late-stage clinical testing. 2. Realty Income Realty Income ( O -0.74% ) isn't a Dividend King like AbbVie. However, the company, which ranks as the world's seventh-largest real estate investment trust (REIT) , has an impressive track record, with its dividend increasing for 30 years in a row. Investors seeking passive income should like Realty Income's forward dividend yield of 5.4%. They should also be pleased that the REIT pays its dividend monthly instead of quarterly. Realty Income even calls itself "The Monthly Dividend Company." The commercial real estate market can sometimes be volatile. The good news with Realty Income is that its portfolio is highly diversified, with over 1,550 clients representing 90 industries. Around 90% of the company's total rent roll is largely insulated from economic downturns and threats from e-commerce. While Realty Income's dividend is its main draw for investors, I think this REIT will be able to deliver solid growth, too. The company has additional opportunities in the U.S. in several areas, including consumer-centric medical facilities, data centers, freestanding retail, and industrial facilities. It has even greater growth prospects in Europe, especially in the U.K., with an estimated total addressable market of $8.5 trillion. 3. Verizon Communications Verizon Communications ( VZ -0.09% ) has been popular with income investors for years -- and for good reason. The telecommunications giant offers a juicy forward dividend yield of 6.07%. This high yield isn't the only plus for Verizon's dividend program. The company has increased its dividend for 18 consecutive years. Sure, Verizon operates in an intensely competitive industry. The company (along with its peers) continually face significant customer churn. These factors have contributed to Verizon's modest revenue growth in recent years. But the telecom leader is still able to generate strong free cash flow ($14.5 billion in the first three quarters of 2024). This resilience should give investors seeking passive income a warm-and-fuzzy feeling about Verizon's dividend. I think Verizon's growth could accelerate by the end of this decade or early in the next decade, though. Some industry experts predict that 6G will debut by 2030. The greater capacity, speed, and reliability of 6G wireless networks could pave the way for a surge in augmented reality and Internet of Things adoption. If so, the demand for Verizon's wireless services should increase significantly.What's better than receiving passive income? Enjoying it for decades. Generating long-term passive income is easier than you might think. Here are three stocks to buy now and hold forever for a lifetime of dividends. 1. AbbVie Let's start with some bona fide dividend royalty. AbbVie ( ABBV -0.08% ) is a Dividend King , with 52 consecutive years of dividend increases. We're not talking about skimpy dividend hikes. Since its spinoff from Abbott Labs in 2013, AbbVie has increased its dividend payout by 310%. The big drugmaker's forward dividend yield currently stands at nearly 3.6%. That's on the low end of AbbVie's dividend yield range in recent years. But there's a good reason for this: AbbVie stock has performed well. I expect AbbVie to continue delivering share price appreciation and growing dividends over the next decade and beyond. Although sales are sliding for the company's top-selling drug, Humira, due to a loss of patent exclusivity, AbbVie has a strong product lineup and pipeline that's stepping up to the plate. In particular, autoimmune disease drugs Rinvoq and Skyrizi should drive AbbVie's revenue growth over the next few years. However, the company has plenty of other rising stars, including migraine therapies Ubrelvy and Qulipta, leukemia drug Venclexta, and antipsychotic drug Vraylar. AbbVie's pipeline also holds tremendous potential, with over 90 programs in clinical development -- more than 50 of which are in mid-to-late-stage clinical testing. 2. Realty Income Realty Income ( O -0.74% ) isn't a Dividend King like AbbVie. However, the company, which ranks as the world's seventh-largest real estate investment trust (REIT) , has an impressive track record, with its dividend increasing for 30 years in a row. Investors seeking passive income should like Realty Income's forward dividend yield of 5.4%. They should also be pleased that the REIT pays its dividend monthly instead of quarterly. Realty Income even calls itself "The Monthly Dividend Company." The commercial real estate market can sometimes be volatile. The good news with Realty Income is that its portfolio is highly diversified, with over 1,550 clients representing 90 industries. Around 90% of the company's total rent roll is largely insulated from economic downturns and threats from e-commerce. While Realty Income's dividend is its main draw for investors, I think this REIT will be able to deliver solid growth, too. The company has additional opportunities in the U.S. in several areas, including consumer-centric medical facilities, data centers, freestanding retail, and industrial facilities. It has even greater growth prospects in Europe, especially in the U.K., with an estimated total addressable market of $8.5 trillion. 3. Verizon Communications Verizon Communications ( VZ -0.09% ) has been popular with income investors for years -- and for good reason. The telecommunications giant offers a juicy forward dividend yield of 6.07%. This high yield isn't the only plus for Verizon's dividend program. The company has increased its dividend for 18 consecutive years. Sure, Verizon operates in an intensely competitive industry. The company (along with its peers) continually face significant customer churn. These factors have contributed to Verizon's modest revenue growth in recent years. But the telecom leader is still able to generate strong free cash flow ($14.5 billion in the first three quarters of 2024). This resilience should give investors seeking passive income a warm-and-fuzzy feeling about Verizon's dividend. I think Verizon's growth could accelerate by the end of this decade or early in the next decade, though. Some industry experts predict that 6G will debut by 2030. The greater capacity, speed, and reliability of 6G wireless networks could pave the way for a surge in augmented reality and Internet of Things adoption. If so, the demand for Verizon's wireless services should increase significantly.